Ginkgo Bioworks Holdings Inc

DNANYSE · USD
8.32USD0.00 (-2.12%)
4210

Ginkgo Bioworks Holdings Inc (DNA) Option Chain

Ginkgo Bioworks Holdings Inc trades at $8.32, down 2.12%, with an IV Rank of 51.59%. This is average versus the past year, and the company carries a market cap of $539M in the Biotechnology industry. On the Nov 20, 2026 chain, the at the money $8.00 strike shows calls at $0.50 / $0.95 and puts at $0.10 / $0.35, both carrying about $0.31 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $9.00 calls, at 10 contracts, and the $8.00 puts, at 23, as of Nov 17, 2026.

Read more

Tracking the DNA option chain helps you see every strike and expiry on Ginkgo Bioworks Holdings Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of DNA options activity at a glance. Use our scanner to monitor the DNA option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For DNA stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where DNA options are being actively traded, and where they are not.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.041400.082.322.052.756.00-27.88—0.600.000.600099.96
3.93710.131.321.101.807.00-15.870.050.100.000.0832396.07
35.7717500.400.320.500.958.00-3.850.100.350.000.23234164.23
80.64126100.250.00—0.259.00+8.170.701.200.680.27413519.36
97.5221650.100.00—0.1010.00+20.191.601.851.680.0523882.48

As of Nov 17, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank51.59% Moderate
  • Market cap (M$)539
  • 52 weeks high-54.34%
  • 52 weeks low54.93%
  • Analyst recommendationSell
    4.33
  • Target price$8.00
    -3.85% below the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-05
  • P/E—
  • Future P/E—
  • EPS (ttm)-4.63
  • EPS growth next 5 years16.87%

As of Nov 17, 2026